First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumerationExpands CNSide contracted payer ...

Among women with breast cancer receiving chemotherapy and primary prophylactic colony-stimulating factor, febrile neutropenia rates remained similar regardless of how the medication was delivered.

IntroductionIn recent years, information security has come to be viewed not just as an IT department issue, but as a ...

You can learn a lot about the students at St. Anthony School in Everett just by looking at the walls. Lining the hallways are ...

BOSTON, Oct. 09, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: XFOR), a company focused on improving the lives of people with rare ...

(Nasdaq: CNSY) (“Cerenome” or the “Company ”), today announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to health care professionals in the ...

Researchers profiling inflammatory proteins in cerebrospinal fluid have identified a signature, including SIRT2 and MMP-1, ...

Starting next year, school choice will be a more attainable option for many American families. Beginning in 2027, the IRS will offer the Education Freedom Tax Credit (EFTC), a tax refund for donations ...

This Saturday, Italy will host the final cycling monument of 2026: the Tour of Lombardy, also known as the Race of the ...

When trustee Alexia Palacios-Peters first joined the school board for the Coronado Unified School District, meetings were ...

Cerenome's CNSide Diagnostics launched two CSF-based molecular profiling tests for CNS cancers, analyzing DNA and RNA.

The National Alliance on Mental Illness helpline is 1-800-950-6264 (NAMI) and provides information and referral services; ...